Balthaser Kevin (CIK 0001957554)

Latest company ownership

Shares held
2,375
Last filed at
Mar 4, 2025
Confidence Score
49.9
2025Q4
Confidence Score History
2023Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 1, 2025 Mar 4, 2025 Aclaris Therapeutics, Inc. CFO Sell 50.0 -727 -0.78% ✗ $1.4K
Feb 1, 2025 Feb 4, 2025 Aclaris Therapeutics, Inc. CFO Sell 46.3 -5,816 -6.08% ✗ $14.4K
Dec 31, 2024 Jan 3, 2025 Aclaris Therapeutics, Inc. CFO Sell 42.5 -38,221 -14.72% ✗ $94.8K
Sep 1, 2024 Sep 4, 2024 Aclaris Therapeutics, Inc. CFO Sell 47.5 -286 -1.14% ✗ $337.5
Mar 1, 2024 Mar 5, 2024 Aclaris Therapeutics, Inc. CFO Sell 47.5 -1,417 -2.04% ✗ $1.8K
Jan 1, 2024 Jan 3, 2024 Aclaris Therapeutics, Inc. CFO Sell 47.5 -2,536 -11.04% ✗ $2.7K
Sep 6, 2023 Sep 7, 2023 Aclaris Therapeutics, Inc. CFO Buy 95.0 +9,490 158.93% ✗ $75K
Sep 1, 2023 Sep 5, 2023 Aclaris Therapeutics, Inc. CFO Sell 47.5 -285 -4.56% ✗ $2.3K
Mar 1, 2023 Mar 3, 2023 Aclaris Therapeutics, Inc. CFO Sell 46.3 -1,894 -16.05% ✗ $23.6K